Chlamydia pneumoniae and atherosclerosis

JAMA

Volumn 282, Issue 21, 1999, Pages 2071-2073

  Shor, Allan ^a,b   Phillips, James I ^a  

^a National Centre for Occupational Health   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; DISEASE ASSOCIATION; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROEPIDEMIOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0033486061     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.21.2071     Document Type: Review

References (42)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995;15:1512-1531.
3. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT, Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841-849.
4. Shor A, Phillips JI, Ong G, Thomas BJ, Taylor-Robinson D. Chlamydia pneumoniae in atheroma: consideration of criteria for causality. J Clin Pathol. 1998; 51:812-817.
5. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydiapsittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-168.
6. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis. 1992;15:757-761.
7. Kuo C, Campbell LA. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol Med Today. 1998;4:426-430.
8. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-986.
9. Saikku P. Chlamydia pneumoniae and atherosclerosis: an update. Scand J Infect Dis Suppl. 1997;104: 53-56.
10. Thom DH, Wang SP, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb. 1991;11:547-551.
11. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350:430-436.
12. Hammerschlag MR. Current knowledge of Chlamydia pneumoniae and atherosclerosis. Eur J Clin Microbiol Infect Dis. 1998;17:305-308.
13. Shor A, Kuo C-C, Patton D. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J. 1992;82:158-161.
14. Taylor-Robinson D, Thomas BJ. Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. J Clin Pathol. 1998;51:793-797.
15. Taylor-Robinson D. Chlamydia pneumoniae in arteries: a tale of the unexpected. J Infect 1997;35:97-98.
16. Weiss SM, Roblin PM, Gaydos CA, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 1996;173:957-962.
17. Lindholt JS, Ostergard L, Henneberg EW, Fasting H, Andersen P. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). Eur J Vasc Endovasc Surg. 1998;15:161-164.
18. Jackson LA, Campbell LA, Schmidt RA, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol. 1997;150:1785-1790.
19. Grayston JT, Campbell LA. The role of Chlamydia pneumoniae in atherosclerosis. Clin Infect Dis. 1999;28:993-994.
20. Ramirez JA, for the Chlamydia pneumoniae/ Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med. 1996;125: 979-982.
21. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 1997;176:292-295.
22. Bartels C, Maass M, Bein C, et al. Detection of Chlamydia pneumoniae but not cytomegalovirus in ocduded saphenous vein coronary artery bypass grafts. Circulation. 1999;99:879-882.
23. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 1998;31:827-832.
24. Esposito G, Blasi F, Allegra L, et al. Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. Ann Vasc Surg. 1999; 13:421-425.
25. Quinn T. Does Chlamydia pneumoniae cause coronary heart disease? Curr Opin Infect Dis. 1998; 11:301-307.
26. Gupta S. Chronic infection in the aetiology of atherosclerosis: focus on Chlamydia pneumoniae. Atherosclerosis. 1999;143:1-6.
27. Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: the final report of the ROXIS study. Eur Heart J. 1999;20:121-127.
28. Anderson JL, Muhlestein JB, Carlquist J, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: the azithromycin in coronary artery disease Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation. 1999;99:1540-1547.
29. Torgano G, Cosentini R, Mandelli C, et al. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation. 1999; 99:1555-1559.
30. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumonias antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997;96:404-407.
31. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998;97:633-636.
32. Yamashita K, Ouchi K, Shirai M, Gondo T, Nakazawa T, Ito H. Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery. Stroke. 1998;29:773-778.
33. Hajjar DP, Nicholson AC. Atherosclerosis. Am Scientist. 1995;83:460-467.
34. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb. 1993;13:1501-1504.
35. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A. 1995;92:6911-6914.
36. Campbell LA, O'Brien ER, Cappucdo AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 1995;172: 585-588.
37. Bauriedel G, Welsch U, Likungu JA, Welz A, Luderitz B. Chlamydia pneumoniae in coronary plaques: increased detection with acute coronary syndrome. Dtsch Med Wochenschr. 1999;124:375-380.
38. Shor A, Phillips J. Histological and ultrastructural findings suggesting an initiating role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis: a study of fifty cases. Cardiovasc J S Afr. In press.
39. Phillips J, Shor A, Murray J, Ong G, Taylor-Robinson D. Myocardial infarction associated with Chlamydia pneumoniae: a case report. Cardiovasc J S Afr. In press.
40. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease. BMJ. 1997;314:1778-1779.
41. Gupta S, Camm AJ. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview. Coron Artery Dis. 1998;9:339-343.
42. Taylor-Robinson D. Chlamydia pneumoniae infection and coronary heart disease: trials should assess whether antibiotics eliminate organism from atherosclerotic lesions. BMJ. 1997;315:1538.